AzTrials
AzTrials

AnesthesiaHYPNOSTIMNOLNCT04630717

Effect of an Hypnotherapy Session on the NOL Variations After Stimulation

A study testing Medical hypnosis session in people with Anesthesia and Hypnosis, run by Ciusss de L'Est de l'Île de Montréal at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators propose to evaluate the analgesic effect of medical hypnosis prior to the pharmacological induction of general anesthesia versus a classical pharmacological induction of anesthesia. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Anesthesia, Hypnosis, Pain
What is being tested?
Medical hypnosis session
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteCanada
Study dates
9 Dec 2020to 10 Mar 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ASA score I, II or III
  • Age 18 years or older
  • Elective laparoscopic surgery under general anesthesia duration less than 3 hours
  • Good understanding of French
  • Acceptance of the protocol

Who cannot join

  • Emergency Surgery
  • Pregnant or breastfeeding woman
  • Pre-operative hemodynamic failure
  • Pathologies of the central nervous system (traumatic sequelae, epilepsy, mental retardation)
  • Dependence on drugs or alcohol in the last 6 months
  • Consumption of chronic psychotropic drugs for more than 3 months
Show all 12Show fewer
  • Morphine consumption or chronic pain requiring a morphine equivalent of 20 mg po daily for more than 6 weeks.
  • Psychiatric pathologies
  • Patient Refusal
  • Allergy or intolerance to one of the products in the study
  • Difficult planned and unplanned intubation
  • Unexpected intraoperative complications (circulatory failure, hemorrhage, etc.)

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • CIUSSS de l'Est de l'Ile de Montreal

    Montreal, Quebec, H1T2M4

Other trials in Canada

About this study

Official title: Effect of an Hypnotherapy Right Before the Induction of Anesthesia Versus Standard Induction on NOL Variations After Standardized Stimulation Performed Under General Anesthesia The HYPNOSTIMNOL Study

The investigators propose to evaluate the analgesic effect of medical hypnosis prior to the pharmacological induction of general anesthesia versus a classical pharmacological induction of anesthesia. Monitoring of the NOL index (Nociception index) as well as all the other classical parameters under general anesthesia (heart rate, blood pressure etc) will allow evaluation of the level of nociception related to oro-tracheal intubation as well as the one related to standardized electrical tetanic stimulation during general anesthesia and before surgical incision, between the two groups.

The investigators know from the literature that the use of medical hypnosis in combination with anesthetic drugs allows for a significant reduction of hypnotic and opioid drugs.

Read more

The investigators aim here at evaluating the real and objective impact of pre-anesthesia hypnosis on intraoperative nociception by using the NOL index which has been developed and used recently to better detect nociceptive stimuli under anesthesia.

This clinical trial will provide an objective answer on the analgesic properties of intraoperative hypnosis. If this is confirmed, hypnosis could find its place in the management of perioperative nociception around general anesthesia.

Read the detailed description

Study Design: Prospective randomized double-blind, mono-centric trial (patient does not know if the conversation is hypnotic or not, the anesthesiologist in charge during the case is not here during the preoperative conversation and is not the one doing the medical conversational hypnosis or standard conversation).

This study proposes to answer two questions :

  • To measure the difference in the variation of the NOL index (delta NOL) after standardized electrical stimulation performed after tracheal intubation under general anesthesia between two types of anesthetic induction : pharmacological induction associated with a brief session of medical hypnosis versus a standard pharmacological induction.
  • To measure variation of heart rate, arterial pressure, BISpectral index after intubation, standardized electrical stimulation, incision and other intraoperative surgical stimuli. Evaluation of postoperative pain, analgesic consumption in the recovery room, and recovery room discharge time. 50 Adults scheduled for elective laparoscopic surgery under general anesthesia expected to last less than 3 hours will be enrolled.

Patients will be informed and included the day before surgery. Randomization will be done by web-base-systeme-algorithm dividing patients into two groups: general anesthesia alone or general anesthesia coupled with hypnosis. No premedication will be administered.

The hypnotherapist will meet briefly with the patient before admission to the operating room to introduce himself.

When the patient enters the operating room, a checklist is performed by the staff, the usual monitoring is set up (electrocardiogram, pulse oximeter, non-invasive blood pressure, muscle relaxation monitor, bispectral index, NOL index). Nasoparyngeal temperature and monitoring of expired carbon dioxide will be placed following tracheal intubation to allow monitoring of normothermia and normo capnia intraoperatively.

The PMD200TM monitor and the BIS index will be connected to the patient. Registration of the index NOL will be done continuously via the PMD200TM monitor, which will be switched on at the start of the procedures.

When everything is ready for pharmacological induction the anesthesiologist in charge will leave the operating room.

In the control arm the therapist will have a standard discussion to check all things are all right with the patient before pharmacological induction starts. No hypnotic conversation will be proposed.

In the hypnosis arm a short session of hypnosis will be done before the pharmacological induction.

The period of discussion in both the groups will be between 6 and 15 minutes, hypnotic or not.

Then, the anesthesiologist will be called for pharmacological induction of general anesthesia.

The protocol of anesthesia will be the same in both groups : the induction will be done by propofol (with a goal of Bispectral index : 40-60) and Remifentanil (with goal of NOL < 25), and muscle relaxation with Rocuronium (0.8 mg.kg-1).

After tracheal intubation, the remifentanil will be discontinued. After a period of at least 10 minutes after remifentanil discontinuation, a standardized tetanic stimulation (70mA, 100Hz, 30 seconds at the ulnar level) will be applied and all the anesthesia parameters and NOL index will be electronically recorded every 5 seconds.

After this stimulation, general anesthesia will be maintained as follows: sevoflurane inhaled anesthesia for a bispectral index between 40-60; remifentanil analgesia for a NOL index between 5-25; rocuronium for a muscle relaxation with TOF index between 1-3. Total consumption of remifentanil during the case will be monitored and calculated in mcg.kg-1 per hour of surgery as it will be a surrogate of intraoperative pain/nociception that will be analyzed too. At the end of surgery, anesthesia is discontinued, hydromorphone 7mcg.kg-1 will be administered at the end of skin closure in anticipation of postoperative pain. Acetaminophen will also be given PR at the end of surgery as well as intravenous ketorolac. Skin incisions for laparoscopic surgery will be infiltrated with 0.5% bupivacaine (maximum 20mL). Once the patient extubated, she/he will be transferred to post anesthesia care unit (PACU) where classical pain management will be offered. Pain scores in PACU, patients' satisfaction, opioid consumption will be evaluated between the two groups in PACU.

Data analysis: The main outcome analyzed will be the delta NOL or the variation of the NOL index between pre and post stimulation in the two groups. The mean maximum value of the NOL index after stimulation will also be compared between the two groups.

Statistical analyses will be performed using SAS version 9.4 or higher and will be performed at a bilateral significance level of 0.05, unless otherwise specified. Descriptive statistics of central tendency (e.g., mean and 95% CI, median) and dispersion (SD, frequency table) will be used to describe the characteristics of the patients in each group of the study. The intraoperative data collected in the groups will be compared using parametric (e.g. Student's t-test) or non-parametric (e.g. Mann-Withney's U-test, Chi-square test) tests depending on the type of variables and their distribution.

Being tested
Medical hypnosis session, control groupe
Keywords
Hypnosis, Anesthesia, Pain, Nociception, NOL
Medical subject headings
Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Medical hypnosis sessionOther

    the therapist will use a standard and identical protocol in all patients: the International characteristics of the hypnosis protocol are the following hypnotic induction through conversational hypnosis and interviewing about leisure activity.

    A catalepsy of the hand or the finger will be done, also to stabilize hypnosis if it is accepted by the patient

  • control groupeOther

    the therapist will use usual voice,loud and strong voice,. clear, high position of the doctor, medical speech focused,no question about the patient's privacy will be made.

Study groups in NCT04630717
Study groupRoleWhat they receive
control groupActive comparatornormal discussion before general anesthesia induction
Receives: Other: control groupe
Hypnosis groupActive comparatorhypnosis session before general anesthesia induction
Receives: Other: Medical hypnosis session

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Delta NOL (no unit for the NOL index)

    To compare the variation of NOL (delta NOL) after tetanic stimulation under general anesthesia based on hypnosis versus standard care group

    Measured: From 1 minute before to 3 minutes after the tetanic stimulation for each patient under general anesthesia

Secondary outcomes (11)
  1. Delta Heart Rate (beat per minute)

    To compare the variation of heart rate (HR) after tetanic stimulation under general anesthesia based on hypnosis versus standard care group

    Measured: From 1 minute before to 3 minutes after the tetanic stimulation for each patient under general anesthesia

  2. Delta Mean Arterial Blood Pressure (unit:mmHg)

    To compare the variation of mean arterial blood pressure (MABP) after tetanic stimulation under general anesthesia based on hypnosis versus standard care group

    Measured: From 1 minute before to 3 minutes after the tetanic stimulation for each patient under general anesthesia

  3. Delta BIS (no unit for BIS index)

    To compare the variation of bispectral index (BIS) after tetanic stimulation under general anesthesia based on hypnosis versus standard care group

    Measured: From 1 minute before to 3 minutes after the tetanic stimulation for each patient under general anesthesia

  4. Peak value of NOL (no unit)

    To compare the peak value of NOL after tetanic stimulation under general anesthesia based on hypnosis versus standard care group

    Measured: From 1 minute before to 3 minutes after the tetanic stimulation for each patient under general anesthesia

  5. Area Under the Curve (AUC) for NOL (no unit)

    To compare the AUC of NOL after tetanic stimulation under general anesthesia based on hypnosis versus standard care group

    Measured: From T0 (start stimulation) to 3 minutes after tetanic stimulation for each patient

  6. Total Dose of Remifentanil (unit: mcg)

    Total dose of remifentanil in mcg from induction of anesthesia until tracheal extubation

    Measured: Intraoperative]

  7. Total Dose of Hydromorphone in post-anesthesia care unit (PACU) (unit: mg)

    Total dose of hydromorphone (mg) in PACU

    Measured: From entrance in PACU until discharge, an average of 2 hours

  8. Pain Scores (scale from 0 to 10) in PACU

    Maximum Pain scores in PACU

    Measured: From entrance in PACU until discharge, an average of 2 hours

  9. Postoperative nausea and vomiting (PONV) score (scale from 0 to 3) in PACU

    PONV score on a scale from 0 (none nausea and vomiting ) to 3 (maximum nausea and vomiting ) in PACU

    Measured: From entrance in PACU until discharge, an average of 2 hours

  10. Pasero Opioid-Induced Sedation Scale (POSS score) (scale from 1 to 4) in PACU

    POSS score on a scale from 1 (sleep, easy to arouse ) to 4 (somnolent, minimal or no response) in PACU

    Measured: From entrance in PACU until discharge, an average of 2 hours

  11. Time for PACU discharge based on Aldrete score (scale from 0 to 10) (in minutes)

    Time (in minutes) for readiness for PACU discharge based on Aldrete score greater than or equal to 9

    Measured: From entrance in PACU until discharge, an average of 2 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Nov 2020
  2. Study start9 Dec 2020
  3. Primary completion1 Dec 2021
  4. Study completion10 Mar 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Prospective randomized double-blind, single-center trial. The patient does not know whether or not he is in the "hypnotic conversation" group; nor does the anesthesiologist managing the patient intraoperatively knows whether or not the patient had a hypnotic conversation prior to general anesthesia induction.
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04630717
Sponsor's protocol ID
2021-2446
Acronym
HYPNOSTIMNOL
Status last verified
Mar 2022
First submitted
28 Oct 2020
Last updated
11 Mar 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Medical hypnosis session in people with Anesthesia and Hypnosis, run by Ciusss de L'Est de l'Île de Montréal at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Delta NOL (no unit for the NOL index) (time frame: From 1 minute before to 3 minutes after the tetanic stimulation for each patient under general anesthesia). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in